Skip to main content

Advertisement

Log in

Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

Some health problems are considered by many individuals as a ‘normal’ part of ageing. Our aim was to investigate whether patients with rheumatoid arthritis (RA) consider different types and levels of health losses as acceptable beyond a certain age. A multicenter cross-sectional survey was performed involving RA patients at the initiation of the first biological therapy. The EQ-5D and the Health Assessment Questionnaire Disability Index (HAQ-DI) questionnaires were used to describe domain-specific health states. Patients were asked to indicate for each domain from what age and onward (between ages 30 and 80 years in 10 year intervals) they considered moderate and severe problems acceptable or alternatively never acceptable. Seventy-seven RA patients (females 86 %, mean age 50.3, disease duration 9.1 years) completed the questionnaire. Disease activity (DAS28), EQ-5D and HAQ-DI scores were mean 6.00 (SD 0.85), 0.35 (SD 0.36), 1.48 (SD 0.66), respectively. The majority of the patients considered age 70 and beyond as acceptable to have some health problems (EQ-5D: self-care 42 %, pain/discomfort 34 %, mobility 33 %, usual activities 33 %, anxiety/depression 27 %), whilst at ages 30 and 40 as not acceptable. Severe health problems were mostly (57–69 %) considered never acceptable, except the ‘Usual activities’ domain (acceptable from age 80 by 50.6 %). The great majority of the patients (77–96 %) were younger than what they indicated as the acceptability age limit. Similar results were found for the HAQ-DI. This small experimental study suggests that RA patients consider some health problems acceptable. This acceptability is age related and varies by health areas. Further larger studies are needed to explore explanatory variables and to compare with other diseases. Owing to the impact acceptability might have on RA patients’ self-evaluation of current health state and decision-making, the topic deserves methodological improvement and further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. WHO: Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948 (1948)

  2. Renehan, E., Dow, B., Lin, X., Blackberry, I., Haapala, I., Gaffy, E., Cyarto, E., Brasher, K., Hendy, S.: Healthy ageing literature review. Victorian Government. http://www.health.vic.gov.au/agedcare/maintaining/downloads/healthy_litreview.pdf (2012). Accessed 28 Feb 2014

  3. Hung, L.-W., Kempen, G.I.J.M., De Vries, N.K.: Cross-cultural comparison between academic and lay views of healthy ageing: a literature review. Ageing Soc. 30(8), 1373–1391 (2010)

    Article  Google Scholar 

  4. Bleichrodt, H., Herrero, C., Pinto, J.L.: A proposal to solve the comparability problem in cost–utility analysis. J. Health Econ. 21(3), 397–403 (2002)

    Article  PubMed  Google Scholar 

  5. Brouwer, W.B., van Exel, N.J., Stolk, E.A.: Acceptability of less than perfect health states. Soc. Sci. Med. 60(2), 237–246 (2005)

    Article  PubMed  Google Scholar 

  6. EuroQol, G.: EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3), 199–208 (1990)

    Article  Google Scholar 

  7. Smolen, J.S., Landewe, R., Breedveld, F.C., Buch, M., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J., Ramiro, S., Winthrop, K., de Wit, M., Aletaha, D., Betteridge, N., Bijlsma, J.W., Boers, M., Buttgereit, F., Combe, B., Cutolo, M., Damjanov, N., Hazes, J.M., Kouloumas, M., Kvien, T.K., Mariette, X., Pavelka, K., van Riel, P.L., Rubbert-Roth, A., Scholte-Voshaar, M., Scott, D.L., Sokka-Isler, T., Wong, J.B., van der Heijde, D.: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. 73(3), 492–509 (2014)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Poulos, C., Hauber, A.B., Gonzalez, J.M., Turpcu, A.: Patients’ willingness to trade off between the duration and frequency of rheumatoid arthritis treatments. Arthritis Care Res (Hoboken) (2013). doi:10.1002/acr.22265

    Google Scholar 

  9. Augustovski, F., Beratarrechea, A., Irazola, V., Rubinstein, F., Tesolin, P., Gonzalez, J., Lencina, V., Scolnik, M., Waimann, C., Navarta, D., Citera, G., Soriano, E.R.: Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment. Value Health 16(2), 385–393 (2013)

    Article  PubMed  Google Scholar 

  10. Meesters, J., de Boer, I., van den Berg, M., Fiocco, M., Vliet Vlieland, T.: Unmet information needs about the delivery of rheumatology health care services: a survey among patients with rheumatoid arthritis. Patient Educ. Couns. 85(2), 299–303 (2011)

    Article  PubMed  Google Scholar 

  11. Harrison, M.J., Davies, L.M., Bansback, N.J., Ingram, M., Anis, A.H., Symmons, D.P.: The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J. Rheumatol. 35(4), 592–602 (2008)

    PubMed  Google Scholar 

  12. Szende, A., Nemeth, R.: Health-related quality of life of the Hungarian population. Orv. Hetil. 144(34), 1667–1674 (2003)

    PubMed  Google Scholar 

  13. Maska, L., Anderson, J., Michaud, K.: Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL). Arthritis Care Res (Hoboken) 63(Suppl 11), S4–S13 (2011)

    Article  Google Scholar 

  14. Péntek, M., Rojkovich, B., Czirják, L., Géher, P., Keszthelyi, P., Kovács, A., Kovács, L., Náfrádi, L., Szanyó, F., Szekanecz, Z., Tamási, L., Tóth, E., Ujfalussy, I., Varjú, T., Gulácsi, L.: Biológikumok Alkalmazása Rheumatoid Arthritisben – Terápiafelmérés (BARAT vizsgálat): biológiai terápiát kezdő betegek klinikai jellemzői és egészségügyi szolgáltatások igénybevételének jellemzői. Immunol. Szle. 3(4), 36–48 (2011)

    Google Scholar 

  15. Péntek, M., Gulácsi, L., Rojkovich, B., Brodszky, V., van Exel, J., Brouwer, W.B.F.: Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists. Eur. J. Health Econ. (2014). doi:10.1007/s10198-014-0597-1

  16. Anderson, J.K., Zimmerman, L., Caplan, L., Michaud, K.: Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res (Hoboken) 63(Suppl 11), S14–S36 (2011)

    Article  Google Scholar 

  17. Radbout University, N.: DAS28. http://www.das-score.nl/das28/en/. Accessed Jan 2014

  18. Buitinga, L., Braakman-Jansen, L.M., Taal, E., van de Laar, M.A.: Worst-case future scenarios of patients with rheumatoid arthritis: a cross-sectional study. Rheumatology (Oxford) 51(11), 2027–2033 (2012)

    Article  Google Scholar 

  19. Buitinga, L., Braakman-Jansen, L.M., Taal, E., van de Laar, M.A.: Future expectations and worst-case future scenarios of patients with rheumatoid arthritis: a focus group study. Musculoskeletal Care 10(4), 240–247 (2012)

    Article  PubMed  Google Scholar 

  20. Sanderson, T., Hewlett, S., Richards, P., Morris, M., Calnan, M.: Utilizing qualitative data from nominal groups: exploring the influences on treatment outcome prioritization with rheumatoid arthritis patients. J. Health Psychol. 17(1), 132–142 (2012)

    Article  PubMed  Google Scholar 

  21. Boncz, I., Sebestyen, A.: Economy and mortality in Eastern and Western Europe between 1945 and 1990: the largest medical trial of history. Int. J. Epidemiol. 35(3), 796–797; author reply 797–799 (2006)

  22. Boncz, I., Sebestyen, A.: Financial deficits in the health services of the UK and Hungary. Lancet 368(9539), 917–918 (2006)

    Article  PubMed  Google Scholar 

  23. Kovacs, A., Dobrossy, L., Budai, A., Boncz, I., Cornides, A.: Cervical screening in Hungary: why does the “English model” work but the “Hungarian model” does not? Eur. J. Gynaecol. Oncol. 29(1), 5–9 (2008)

    CAS  PubMed  Google Scholar 

  24. Krishnan, E., Sokka, T., Hakkinen, A., Hubert, H., Hannonen, P.: Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population. Arthritis Rheum. 50(3), 953–960 (2004)

    Article  PubMed  Google Scholar 

  25. Sokka, T., Makinen, H., Hannonen, P., Pincus, T.: Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Rheumatology (Oxford) 46(6), 1020–1023 (2007)

    Article  CAS  Google Scholar 

  26. Sallai, J.R., Hunka, A., Hejj, G., Ratko, I., Ortutay, J., Markus, I., Ormos, G., Ujfalussy, A., Szekeres, L., Insperger, A., Varju, T., Balint, G.: Survey of quality of life of rheumatoid arthritis patients admitted to rehabilitation centres in Hungary. Orv. Hetil. 154(35), 1381–1388 (2013)

    Article  PubMed  Google Scholar 

  27. Cutolo, M., Kitas, G.D., van Riel, P.L.: Burden of disease in treated rheumatoid arthritis patients: going beyond the joint. Semin. Arthritis Rheum. 43(4), 479–488 (2014)

    Article  PubMed  Google Scholar 

  28. Marra, C.A., Woolcott, J.C., Kopec, J.A., Shojania, K., Offer, R., Brazier, J.E., Esdaile, J.M., Anis, A.H.: A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc. Sci. Med. 60(7), 1571–1582 (2005)

    Article  PubMed  Google Scholar 

  29. Felson, D.T., Anderson, J.J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L.M., Lightfoot Jr, R., Paulus, H., Strand, V., et al.: American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 38(6), 727–735 (1995)

    Article  CAS  PubMed  Google Scholar 

  30. Pease, C., Pope, J.E., Truong, D., Bombardier, C., Widdifield, J., Thorne, J.C., Paul Haraoui, B., Psaradellis, E., Sampalis, J., Bonner, A.: Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. Semin. Arthritis Rheum. 41(1), 81–89 (2011)

    Article  CAS  PubMed  Google Scholar 

  31. Kobelt, G.: Thoughts on health economics in rheumatoid arthritis. Ann. Rheum. Dis. 66(Suppl 3), iii35–39 (2007)

Download references

Acknowledgments

The authors are grateful to the patients who participated in the study. The survey would not have been possible without the valuable work of the following colleagues: Fülöp A and Tandari M (Budapest); Bodnár N, Szamosi Sz, Szűcs G and Váncsa A (Debrecen); Abrudán K, Kovács H and Závada Zs (Gyula); Szanyó F (Győr); Böjte Gy, Eiben A and Sterba G (Kistarcsa); Fazekas K, Flórián Á and Lukács K (Miskolc); Encs E, Tisza A and Varjú T (Nyíregyháza); Balogh A and Hulló D (Szeged); Baksay B, Bíró J and Gácsi K (Szolnok); Náfrádi L (Szombathely); and Niedermayer D and Varjú C (Pécs). The survey was supported by an independent grant from the Centre for Public Affairs Studies Foundation and HTA Co. The work was supported by the European Union and the State of Hungary co-financed by the European Social Fund in the framework of TÁMOP-4.2.4.A/2-11/1-2012-0001 ‘National Excellence Program’ (Z.S., Debrecen), and the University of Debrecen, Faculty of Medicine Bridging Fund (Z.S., Debrecen). The proofreading of the manuscript was supported by the TÁMOP 4.2.2./B-10/1-2010-0023 project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Márta Péntek.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Péntek, M., Rojkovich, B., Czirják, L. et al. Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective. Eur J Health Econ 15 (Suppl 1), 73–82 (2014). https://doi.org/10.1007/s10198-014-0596-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-014-0596-2

Keywords

JEL Classification

Navigation